Exchange Traded Concepts’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.3M Buy
58,530
+28,938
+98% +$8.33M 0.13% 200
2025
Q4
$8.97M Buy
29,592
+8,012
+37% +$2.5M 0.07% 283
2025
Q3
$6.05M Buy
21,580
+7,648
+55% +$2.08M 0.06% 344
2025
Q2
$3.36M Buy
13,932
+7,697
+123% +$1.82M 0.04% 395
2025
Q1
$1.52M Buy
6,235
+3,973
+176% +$1.2M 0.03% 447
2024
Q4
$743K Sell
2,262
-10
-0.4% -$3.39K 0.02% 703
2024
Q3
$760K Sell
2,272
-884
-28% -$281K 0.02% 653
2024
Q2
$862K Buy
3,156
+154
+5% +$44.8K 0.02% 485
2024
Q1
$1.04M Buy
3,002
+355
+13% +$117K 0.03% 432
2023
Q4
$855K Sell
2,647
-491
-16% -$154K 0.02% 437
2023
Q3
$1.12M Sell
3,138
-708
-18% -$273K 0.03% 364
2023
Q2
$1.46M Buy
3,846
+961
+33% +$391K 0.04% 321
2023
Q1
$1.38M Sell
2,885
-911
-24% -$426K 0.04% 268
2022
Q4
$1.6M Buy
3,796
+807
+27% +$326K 0.05% 221
2022
Q3
$1.25M Buy
2,989
+188
+7% +$93.7K 0.04% 219
2022
Q2
$1.39M Sell
2,801
-644
-19% -$335K 0.04% 227
2022
Q1
$1.94M Buy
3,445
+46
+1% +$27.7K 0.04% 230
2021
Q4
$2.57M Sell
3,399
-482
-12% -$361K 0.05% 220
2021
Q3
$2.9M Sell
3,881
-1,733
-31% -$1.3M 0.07% 192
2021
Q2
$3.62M Buy
5,614
+338
+6% +$206K 0.11% 136
2021
Q1
$3.01M Buy
5,276
+1,701
+48% +$1.01M 0.11% 129
2020
Q4
$2.08M Buy
3,575
+1,642
+85% +$935K 0.1% 139
2020
Q3
$996K Buy
1,933
+578
+43% +$293K 0.06% 171
2020
Q2
$612K Buy
1,355
+977
+258% +$431K 0.1% 168
2020
Q1
$133K Buy
378
+150
+66% +$55.2K 0.07% 233
2019
Q4
$84K Buy
+228
New +$80.4K 0.02% 223

Other funds holding BIO